NCT04018703

Brief Summary

Due to the delicacy and long duration of the procedure, ophthalmic surgery put forward higher requirements to anesthesia management:

  1. 1.The patient with local anesthesia without sedation is in a state of awareness, which will cause intense stress resulting in increased blood pressure, heart rate, muscle tension and even sense of pain;
  2. 2.Traction of extraocular muscles and eyeballs can induce oculocardiac reflex, followed by bradycardia, atrial or ventricular arrhythmia, conduction block, and even more worsen, life-threatening cardiac arrest may occur;
  3. 3.With the increase in average life expectancy and the improvement of quality of life requirements, the number of elderly patients in ophthalmic surgery is also increasing. These elderly patients are often combined with hypertension, diabetes, etc. and decreased tolerance of with general anesthesia;
  4. 4.For some retinal detachment surgery with difficulty in resetting, the patients will be required to change to the prone position immediately after surgery to improve the success rate of resetting. Conventional general anesthesia management are cumbersome and costly, which may not be likely to achieve the swift emergence.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 12, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

November 3, 2020

Status Verified

November 1, 2020

Enrollment Period

1.7 years

First QC Date

July 9, 2019

Last Update Submit

November 1, 2020

Conditions

Keywords

Monitored anesthesia careOphthalmic surgeryDexmedetomidineMidazolam

Outcome Measures

Primary Outcomes (2)

  • Perioperative change of Observer's Assessment of Alertness/Sedation scale (OAA/S)

    Conventional subjective sedation scales with 1 to 5. Successful sedation was defined as an OAA/S scale score between 1 and 3, while failure was defined as an OAA/S score of more than 3.

    OAA/S score will be recorded from patient arrival in the operating room to about 30 minutes after surgery at following time points: before sedative administration, before skin incision, every 5 minutes intraoperatively and every 10 minutes in PACU.

  • Numerical rating scale (NRS)

    The surgeons rated anesthesia management on a numerical rating scale (NRS), ranging from 0 to 10, with 10 defined as the best condition and 0 as the worst.

    Immediately after surgery, the surgeons report NRS only once

Secondary Outcomes (3)

  • Intraocular pressure

    Intraocular pressure will be measured at two time points: before sedative medication administration and before skin incision.

  • Bispectral index (BIS)

    Bis will be continuously recorded with BIS monitor from arrival in the operating room to discharge to ward (about 30 minutes after surgery).

  • Visual analogue scale (VAS)

    VAS will be recorded at the following time points until 1h postoperatively: before sedative medication administration, before skin incision, every 10 minutes intraoperatively and 1h postoperatively

Study Arms (2)

Dexmedetomidine

EXPERIMENTAL

Dexmedetomidine will be used for perioperative sedation.

Drug: Dexmedetomidine

Midazolam

EXPERIMENTAL

Midazolam will be used for perioperative sedation.

Drug: Midazolam

Interventions

loading dose 0.5-2.5ug/kg followed by continuous infusion 0.2-0.5ug/kg/h

Dexmedetomidine

loading dose 30-50ug/kg followed by continuous infusion 10-30ug/kg/h

Midazolam

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for ophthalmic surgery with retrobulbar nerve block

You may not qualify if:

  • Patients with severe cardiac, pulmonary, hepatic, or renal dysfunction. Patients with a preoperative history of mental disorder, hearing disorder, II-III degree atrioventricular block, known allergy or hypersensitivity to a2 receptor agonists and refusal of (or contraindications to) PNB. Patients with anticipated difficult airway.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eye, Ear, Nose and Throat Hospital

Shanghai, Shanghai Municipality, 200031, China

RECRUITING

MeSH Terms

Interventions

DexmedetomidineMidazolam

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsBenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • Wenxian Li, M.D. Ph.D.

    Eye and ENT Hospital of Fudan University

    STUDY DIRECTOR

Central Study Contacts

Hui Qiao, M.D. Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Anesthesiologist

Study Record Dates

First Submitted

July 9, 2019

First Posted

July 12, 2019

Study Start

November 1, 2019

Primary Completion

July 31, 2021

Study Completion

December 31, 2021

Last Updated

November 3, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations